1.Invited Commentary: Role of Estrogen Receptor-alpha in Regulating Claudin-6 Expression in Breast Cancer Cells.
Journal of Breast Cancer 2011;14(1):76-77
No abstract available.
Breast
;
Breast Neoplasms
;
Claudins
;
Estrogens
2.Microglandular Adenosis.
Dong Ju KIM ; Woo Young SUN ; Dong Hee RYU ; Jin Woo PARK ; Hyo Young YUN ; Jae Woon CHOI ; Young Jin SONG
Journal of Breast Cancer 2011;14(1):72-75
Microglandular adenosis (MGA) of the breast is a very rare and benign proliferative lesion. Most patients complain of a palpable breast mass that may arouse a clinical suspicion of breast cancer. Histopathologically, it is hard to distinguish MGA from breast cancer because of the lack of a myoepithelial layer and infiltrative proliferation. Several studies have reported a strong relationship between MGA and carcinoma arising in MGA, so the mass should be excised completely in cases of MGA determined from a core needle biopsy rather than observation. A 72-years-old woman presented with a palpable breast mass. On physical examination, a mass was palpable in the right upper outer quadrant area and somewhat fixed to the surrounding tissues and pectoralis major muscle. We could not detect any mass or dense lesion on mammography because of a grade 4 dense breast. Ultrasonographic findings revealed a low echoic lesion with indistinct margins. The result of a core needle biopsy was MGA, which was confirmed by excision. We report one case of MGA, which was believed to breast cancer clinically.
Biopsy, Large-Core Needle
;
Breast
;
Breast Neoplasms
;
Female
;
Fibrocystic Breast Disease
;
Humans
;
Mammography
;
Muscles
;
Physical Examination
3.Solitary Small Bowel Metastasis from Breast Cancer.
Jung Eun CHOI ; Shin Young PARK ; Myung Hoon JEON ; Su Hwan KANG ; Soo Jung LEE ; Young Kyung BAE ; Min Kyoung KIM
Journal of Breast Cancer 2011;14(1):69-71
The common sites of metastasis of breast cancer are bone, lung, and liver, but gastrointestinal metastasis from breast cancer is rare. We experienced a case of solitary ileal metastasis from breast cancer. A 45-years-old woman presented with melena for several weeks. She showed no other abdominal symptoms. Colonoscopy findings showed an ulcerative mucosal lesion in the terminal ileum, and biopsy was performed. Pathologic examination revealed metastatic carcinoma, originated from breast. The tumor cells were positive for estrogen receptor and negative for Cdx-2. She had had a previous medical history of bilateral breast cancer and undergone breast conserving surgery with sentinel lymph node biopsy for both breasts. The torso positron emission tomography scan at 19 months after surgery showed mildly increased uptake in the terminal ileum which was considered as inflammation. Finally, she was diagnosed with solitary ileal metastasis from breast cancer at 22 months after surgery.
Biopsy
;
Breast
;
Breast Neoplasms
;
Colonoscopy
;
Estrogens
;
Female
;
Gastrointestinal Tract
;
Humans
;
Ileum
;
Inflammation
;
Liver
;
Lung
;
Mastectomy, Segmental
;
Melena
;
Neoplasm Metastasis
;
Nitriles
;
Positron-Emission Tomography
;
Pyrethrins
;
Sentinel Lymph Node Biopsy
;
Torso
;
Ulcer
4.Lateral Decubitus Positioning Stereotactic Vacuum-Assisted Breast Biopsy with True Lateral Mammography.
Youn Joo JUNG ; Young Tae BAE ; Jee Yeon LEE ; Hyung Il SEO ; Jee Yeon KIM ; Ki Seok CHOO
Journal of Breast Cancer 2011;14(1):64-68
Stereotactic vacuum-assisted breast biopsy (VAB) has been used to evaluate microcalcifications or non-palpable breast lesions on mammography. Although stereotactic VAB is usually performed in a prone or upright position, an expensive prone table is necessary and vasovagal reactions often occur during the procedure. For these reasons, the lateral decubitus position can be applied for stereotactic VAB, and true lateral mammography can be used to detect the lesion. We report on 15 cases of lateral decubitus positioning for stereotactic VAB with true lateral mammography for non-palpable breast lesions or microcalcifications. The mean procedure time was approximately 30.1 minutes, and no complications occurred during the procedures. Fourteen cases had benign breast lesions and one case had a ductal carcinoma in situ. The lateral decubitus stereotactic VAB with true lateral mammography can be applied for microcalcifications or non-palpable breast lesions and helps to minimize anxiety and vasovagal reactions in patients.
Anxiety
;
Biopsy
;
Breast
;
Carcinoma, Intraductal, Noninfiltrating
;
Humans
;
Mammography
;
Stereotaxic Techniques
5.Painless Posterior Thigh Mass as a Presentation of Metastatic Breast Cancer.
Hyun Min CHO ; Myung Su KO ; Ji Hye LEE ; Won Sang JUNG ; Hyun Joo CHOI ; Se Jeong OH ; Young Jin SUH
Journal of Breast Cancer 2010;13(4):448-451
Soft tissue metastasis clinically presenting as either painless subcutaneous or painful intramuscular nodules is extremely rare and may lead to an errant clinical suspicion of sarcoma. In general, most soft tissue metastasis comes from lung carcinoma; however, to date, there have been no reports of a posterior thigh mass just beneath the skin metastasizing from breast cancer. Here, we report a case of distant soft tissue metastasis presenting as a painless solitary left posterior thigh mass measuring 1.5 cm in diameter, which was later shown by positron emission tomography-computed tomography (PET-CT) to have multiple simultaneous mediastinal lymph node metastases. Eleven months ago, the patient had undergone curative breast-conserving surgery (BCS) for cancer of her left breast. At that time, her tumor showed a triple negative phenotype. Initial PET-CT right before the BCS had shown no metastasis. After histological and radiologic evaluation for the metastases, she decided to have systemic chemotherapy.
Breast
;
Breast Neoplasms
;
Electrons
;
Humans
;
Lung
;
Lymph Nodes
;
Mastectomy, Segmental
;
Neoplasm Metastasis
;
Phenotype
;
Sarcoma
;
Skin
;
Thigh
6.Intrapleural Paclitaxel Chemotherapy in the Treatment of Breast Cancer-Related Metastatic Malignant Pleural Effusion.
Shin Young PARK ; Jung Eun CHOI ; Myung Hoon JEON ; Su Hwan KANG ; Soo Jung LEE
Journal of Breast Cancer 2010;13(4):443-447
Malignant pleural effusion in breast cancer has been associated with poor prognosis. The response rate of local treatment has been very low and in some case, complications have resulted in death. We investigated the efficacy and safety of paclitaxel, as an intrapleural chemotherapeutic agent. From January 2006 to December 2009, ten breast cancer patients who had developed malignant pleural effusion were infused with intrapleural paclitaxel through a chest tube, which was clamped for 48 hours. The chest tube was maintained until drainage was reduced to less than 50-100 mL/day. The average time spent with a chest tube attached following intrapleural chemotherapy was 9.3 days. During the follow-up period, six patients had no recurrent pleural effusion and two received a second round of intrapleural chemotherapy following which no further pleural effusion recurred. There were no severe side effects except for mild toxicity. It is suggested that intrapleural paclitaxel chemotherapy may be superior to conventional local treatment and may represent an effective treatment modality with low toxicity.
Breast
;
Breast Neoplasms
;
Chest Tubes
;
Drainage
;
Follow-Up Studies
;
Humans
;
Paclitaxel
;
Pleural Effusion
;
Pleural Effusion, Malignant
;
Prognosis
7.Single-Port Access Laparoscopic Prophylactic Bilateral Salpingo-Oophorectomy in BRCA-Positive Breast Cancer Patient: A Case Report.
Tae Joong KIM ; Min Young CHOI ; Se Kyung LEE ; Sung Mo HUR ; Sangmin KIM ; Min Young KOO ; Soo Youn BAE ; Dong Hui CHO ; Jun Ho CHOE ; Jung Han KIM ; Jee Soo KIM ; Byoung Gie KIM ; Duk Soo BAE ; Jeong Eon LEE ; Seok Jin NAM ; Jung Hyun YANG
Journal of Breast Cancer 2010;13(4):437-442
For women with a BRCA 1/2 mutation, prophylactic bilateral salpingo-oophorectomy (BSO) is known to reduce the risk of developing both ovarian and breast cancer. The increasing interest in hereditary breast cancer has recently resulted in frequent genetic testing for high-risk patients. Since breast surgeons frequently encounter BRCA-positive breast cancer patients or carriers in the outpatient clinic, it is a prerequisite that the decision of the patients and doctors should be based on a thorough understanding of the objective risk, the medical assessment and the various treatment options, including surgery and anti-cancer therapy. The risk for the ovarian cancer also makes up an important part of genetic counseling; therefore, the breast surgeons should be well aware of this. This report presents the first experience with performing single-port access laparoscopic prophylactic BSO for a BRCA-positive breast cancer patient, and this procedure was technically feasible and the patient had minimal scar. However, a future investigation is needed to properly assess the cosmetic outcome in this approach.
Ambulatory Care Facilities
;
Breast
;
Breast Neoplasms
;
Cicatrix
;
Cosmetics
;
Female
;
Genetic Testing
;
Humans
;
Laparoscopy
;
Ovarian Neoplasms
8.The Reliability and Validity of World Health Organization Quality of Life Assessment Instrument (WHOQOL) in Patients with Breast Cancer: Physical Domain and Depression.
E Jin PARK ; Eun Jeong MOON ; Hoon CHOI ; Se Jeong OH ; Yang Whan JEON ; Sang Ick HAN
Journal of Breast Cancer 2010;13(4):431-436
PURPOSE: This study was designed to investigate the reliability and validity of the World Health Organization Quality of Life Assessment Instrument (WHOQOL) in patients with breast cancer according to depressive symptoms. METHODS: One-hundred seventeen patients with breast cancer who had undergone a radical operation were recruited. The 100 item-WHOQOL instrument and Hamilton Rating Scale for Depression were used to measure all the subjects. The five domain scores, except for the WHOQOL spiritual domain, were compared between patients with and without depressive symptoms, and then the reliability and validity of the five domains were calculated. RESULTS: Depressed patients with breast cancer had lower scores in all five domains of the WHOQOL than those who were not depressed in all five domains of WHOQOL [df=(1, 115), F=46.6, p<0.001]. Reliability and validity in the physical domain of depressed patients with breast cancer decreased markedly. CONCLUSION: WHOQOL is a valid and useful instrument for evaluating the quality of life in patients with breast cancer, but is limited in scoring of depressed patients with breast cancer, particularly in the physical domain. Therefore, quality of life must be interpreted with carefully hand in depressed patients with breast cancer.
Breast
;
Breast Neoplasms
;
Depression
;
Hand
;
Humans
;
Quality of Life
;
Reproducibility of Results
;
World Health
;
World Health Organization
9.The Change of Practice Patterns of the Hereditary Breast Cancer Management in Korea after the Korean Hereditary Breast Cancer Study.
Eunyoung KANG ; Sei Hyun AHN ; Woo Chul NOH ; Dong Young NOH ; Yongsik JUNG ; Lee Su KIM ; Doo Ho CHOI ; Young Jin SUH ; Ku Sang KIM ; Jeong Eon LEE ; Min Hyuk LEE ; Seok Jin NAM ; Byung In MOON ; Byung Ho SON ; Jung Hyun YANG ; Cha Kyong YOM ; Sung Yong KIM ; Sue K PARK ; Sung Won KIM
Journal of Breast Cancer 2010;13(4):418-430
PURPOSE: The objective of this study was to evaluate the change in the practice patterns for managing hereditary breast and ovarian cancer (HBOC) among Korean physicians after the Korean Hereditary Breast Cancer (KOHBRA) study. METHODS: The first survey was performed from July to August 2007, at the initiation of the KOHBRA study, and the follow-up survey was conducted from July to December 2009. Members of the Korean Breast Cancer Society were invited to participate in the study by e-mail. The 2009 survey was conducted with a self-administered questionnaire concerning HBOC management and was identical to the previous questionnaire. RESULTS: According to the 2009 survey, most physicians (60.0%) tended to draw a pedigree (48.0% in 2007 survey). The rate of genetic test recommendations for patients at risk for HBOC was higher in the 2009 survey (84.0%) than that in the 2007 survey (64.0%). Physicians tended to select a BRCA genetic testing candidate more appropriately than in the previous survey (42.4% answered right in 2007 survey; 74.4% in 2009 survey). Fifteen of 25 participants (60.0%) provided genetic counseling before their patients underwent a genetic test, which was higher than that (40.0%) in the 2007 survey. According to the 2009 survey, half of the genetic counseling was being conducted by KOHBRA study research nurses; whereas most of the genetic counseling was conducted by physicians in 2007. CONCLUSION: The KOHBRA study has played an important role in the appropriate selection of candidates for genetic testing. However, more effort should be placed on improving the pre-test genetic counseling rate.
Breast
;
Breast Neoplasms
;
Electronic Mail
;
Follow-Up Studies
;
Genetic Counseling
;
Genetic Testing
;
Humans
;
Korea
;
Neoplastic Syndromes, Hereditary
;
Ovarian Neoplasms
;
Pedigree
;
Physician's Practice Patterns
;
Surveys and Questionnaires
10.Charlson Comorbidity Index as a Predictor of Long-Term Survival after Surgery for Breast Cancer: A Nationwide Retrospective Cohort Study in South Korea.
Hye Kyung WOO ; Jong Hyock PARK ; Han Sung KANG ; So Young KIM ; Sang Il LEE ; Hyung Ho NAM
Journal of Breast Cancer 2010;13(4):409-417
PURPOSE: The aim of this article was to evaluate the impact of the Charlson Comorbidity Index (CCI) on long-term survival after surgery for breast cancer in South Korea. METHODS: The study subjects were 29,562 women patients aged 20 years and older that underwent surgery for breast cancer between 2002 and 2005. The data were obtained from claims submitted to the National Health Insurance. All patients were censored at the follow-up cutoff date of June 30, 2006. Survival curves were estimated by the Kaplan-Meier method. Cox proportional hazards models were used to explore the impact of CCI on all-cause mortality. RESULTS: After a follow-up time of 47 months, higher all-cause mortality was associated with an increasing CCI. In terms of the 4-year survival rate, among patients with CCI=1, it was 91.1%, among patients with CCI=2 it was 87.8%, and those patients with CCI> or =3 it was 80.2%. Multivariate Cox proportional hazard analysis showed that CCI=1 (hazard ratios [HR], 1.10; 95% confidence interval [CI], 0.97-1.25), CCI=2 (HR, 1.61; 95% CI, 1.31-1.97) and CCI> or =3 (HR, 2.27; 95% CI, 1.59-3.24), were associated with long-term survival. CONCLUSION: CCI is a strong predictor of long-term survival after surgery for breast cancer. We recommend the use of a validated comorbidity index in the selection of patients for breast surgery.
Aged
;
Breast
;
Breast Neoplasms
;
Cohort Studies
;
Comorbidity
;
Female
;
Follow-Up Studies
;
Humans
;
National Health Programs
;
Proportional Hazards Models
;
Republic of Korea
;
Retrospective Studies
;
Survival Rate